Company News
Aurobindo Pharma Receives USFDA Approval for Perampanel
Aurobindo Pharma received USFDA final approval for Perampanel Tablets across six dosage strengths for epilepsy treatment.
The product has an estimated market size of $67 million and will be manufactur
